As shown in this study, inhibition of IFITM2 significantly inhibited PI3K/AKT activation in CRC cells, suggesting that the cancer-promoting effect of IFITM2 in CRC may be related to its regulation of the PI3K/AKT signaling pathway. The gene discussed is IFITM2; the disease is cancer.